Skip to content

Outcomes of Differentiated Models of Service Delivery for HIV Treatment at Sentinel Sites in South Africa

Outcomes of Differentiated Models of Service Delivery for HIV Treatment at Sentinel Sites in South Africa (Sentinel-South Africa)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306693114717
Enrollment
15520
Registered
2023-06-26
Start date
2021-08-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Domain 1 Provider time
Domain 2 Provider experiences
Domain 3 Patient experiences with service delivery
Domain 4 Resources
Domain 5 Patient experience with differentiated HIV testing

Sponsors

Bill and Melinda Gates Foundation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Domain 1 (Provider time) ? Patient-facing or patient-supporting service provider at the study site (patient-supporting providers include data clerks, pharmacists, etc.) ? Directly or indirectly involved in the site’s implementation of ART and DSD models ? Employed in current role at the study site for at least six months ? Provides written informed consent to participate Domain 2 (Provider experiences) ? Direct or indirect service provider at the study site (indirect providers include supervisors, technical advisors, etc.) ? Directly or indirectly involved in the site’s implementation of ART and DSD models ? Employed in current role at the study site for at least six months ? Provides written informed consent to participate. Domain 3 (Patient experiences with service delivery) ? Living with HIV and on ART for at least six months at the study site ? = 18 years old (18 and older considered adult for research purposes in South Africa) ? Enrolled in a specified model of care (including conventional care) up to the target number of participants for that model and have received at least one medication refill under this model ? Provide written informed consent to participate Domain 5 (Patient experience with differentiated HIV testing) ? Undergoing HIV testing at the study site or other testing site within the catchment area ? = 18 years old (18 and older considered adult for research purposes in South Africa) ? Provide written informed consent to participate.

Exclusion criteria

Exclusion criteria: Domain 1 (Provider time) ? None Domain 2 (Provider experiences) ? Direct or indirect service provider at the study site (indirect providers include supervisors, technical advisors, etc.) ? Directly or indirectly involved in the site’s implementation of ART and DSD models ? Employed in current role at the study site for at least six months ? Provides written informed consent to participate. Domain 3 (Patient experiences with service delivery) ? Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant ? Not physically, mentally, or emotionally able to participate in the study, in the opinion of the investigators or study staff. ? Unwilling to take the time required to complete the questionnaire on the day of consent. Domain 5 (Patient experience with differentiated HIV testing) ? Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant ? Not physically, mentally, or emotionally able to participate in the study, in the opinion of the investigators or study staff. ? Unwilling to take the time required to complete the questionnaire on the day of consent.

Design outcomes

Primary

MeasureTime frame
Increased clinic efficiency and capacity;Lower costs to providers and patients;Better health outcomes for HIV and non-HIV patients;Improved access and greater satisfaction with healthcare for patients

Secondary

MeasureTime frame
Provider and patient satisfaction

Countries

South Africa

Contacts

Public ContactIdah Mokhele

Senior Researcher

imokhele@heroza.org0100017930

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026